Washington Post Examines Development Of Vaccine For Food Borne Intestinal Illness

The Partnership for Public Service/Washington Post examines how decades of work by Navy scientist Patricia Guerry could lead to “the first vaccine for a food borne intestinal illness that affects hundreds of millions of people worldwide each year.”

“The vaccine candidate against the pathogen Campylobacter jejuni, developed by Guerry, her colleagues at the U.S. Naval Medical Research Center in Silver Spring and Canadian scientist Mario Monteiro, successfully protected against infection in monkeys during testing last year and is slated for human clinical trials,” the newspaper writes.

According to the Washington Post, an “effective vaccine … could potentially save tens of thousands of young lives in developing countries where the pathogen has proved deadly,” the newspaper writes. The article includes additional information about how the vaccine was developed (8/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.


KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.